We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
RNS No 2950b CAMBRIDGE ANTIBODY TECHNOLOGY GROUP 30th November 1998 Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: John Aston 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): CAT Group Employees Trustees Limited 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Appropriation of shares on behalf of Director to Inland Revenue approved Staff Share Scheme administered by CAT Group Employees Trustees Limited and a separate grant of options. 7 Number of shares/amount of stock acquired: 400 8 Percentage of issued class: 0.01% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 242p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 1627 16 Total percentage holding of issued class following this notification: 0.006% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: November 27 1998 18 Period during which or date on which exercisable: November 27 2001 - November 26 2005 19 Total amount paid (if any) for grant of the option: Nil 20 Description of shares or debentures involved: class, number: 10p ordinary shares 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 242p 22 Total number of shares or debentures over which options held following this notification: 143 964 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: David Chiswell 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 and CAT Group Employees Trustees Limited 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Exercise of 375,000 options and transfer of same to Linda Chiswell spouse and appropriation of shares on behalf of Director to Inland Revenue approved Staff Share Scheme administered by CAT Group Employees Trustees Limited and a separate grant of options. 7 Number of shares/amount of stock acquired: 375,400 8 Percentage of issued class: 1.59% 9 Number of shares/amount of stock disposed: 375,000 ( to spouse) 10 Percentage of issued class: 1.59% 11 Class of security: 10p ordinary shares 12 Price per share: 242p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 625,627 (with spouse) 16 Total percentage holding of issued class following this notification: 2.66% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: November 27 1998 18 Period during which or date on which exercisable: November 27 2001- November 26 2005 19 Total amount paid (if any) for grant of the option: Nil 20 Description of shares or debentures involved: class, number: 16,116 10p ordinary shares 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 242p 22 Total number of shares or debentures over which options held following this notification: 166,116 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: David Glover 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): CAT Group Employees Trustees Limited 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Appropriation of shares on behalf of Director to Inland Revenue approved Staff Share Scheme administered by CAT Group Employees Trustees Limited and a separate grant of options. 7 Number of shares/amount of stock acquired: 400 8 Percentage of issued class: 0.001% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 242p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 6827 16 Total percentage holding of issued class following this notification: 0.03% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: November 27 1998 18 Period during which or date on which exercisable: November 27 2001-November 26 2005 19 Total amount paid (if any) for grant of the option: Nil 20 Description of shares or debentures involved: class, number: 29,964 10p ordinary shares 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 242p 22 Total number of shares or debentures over which options held following this notification: 119,964 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Kevin Johnson 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 and CAT Group Employees Trustees Limited 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Exercise of 62,500 options and transfer of 31,200 to Sue Johnson spouse and appropriation of shares on behalf of Director to Inland Revenue approved Staff Share Scheme administered by CAT Group Employees Trustees Limited and a separate grant of options. 7 Number of shares/amount of stock acquired: 62,900 8 Percentage of issued class: 0.27% 9 Number of shares/amount of stock disposed: 31,250 transferred to spouse 10 Percentage of issued class: 0.13% 11 Class of security: 10p ordinary shares 12 Price per share: 242p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 63,127 (with spouse) 16 Total percentage holding of issued class following this notification: 0.27% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: November 27 1998 18 Period during which or date on which exercisable: November 27 2001-November 26 2005 19 Total amount paid (if any) for grant of the option: Nil 20 Description of shares or debentures involved: class, number: 28324 10p ordinary shares 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 242p 22 Total number of shares or debentures over which options held following this notification: 118,324 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Alistair Cumming 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Grant of 1000 shares in lieu of non executive remuneration of #5000 7 Number of shares/amount of stock acquired: 1000 8 Percentage of issued class: 0.04% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 500p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 4100 16 Total percentage holding of issued class following this notification: 0.017% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: James Foght 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: Non-beneficial interest in shares granted to Vector Fund Management in lieu of Director's non executive remuneration 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): Vector Fund Management 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Grant of 1000 shares to Vector Fund Management in lieu of non executive remuneration of #5000 7 Number of shares/amount of stock acquired: 1000 8 Percentage of issued class: 0.04% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 500p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: Nil 16 Total percentage holding of issued class following this notification: If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Peter Garland 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: Non beneficial interest in holding of Institute of Cancer Research of 2000 shares granted to Institute in lieu of Director's non executive remuneration 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): Institute of Cancer Research 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 2000 shares granted to Institute of Cancer Research in lieu of Director's non executive remuneration of #10,000 7 Number of shares/amount of stock acquired: 2000 8 Percentage of issued class: 0.08% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 500p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 78,752 16 Total percentage holding of issued class following this notification: 0.34% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Sir Aaron Klug 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Grant of 1000 shares in lieu of non executive remuneration of #5000 7 Number of shares/amount of stock acquired: 1000 8 Percentage of issued class: 0.04% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 500p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 1500 16 Total percentage holding of issued class following this notification: 0.006% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: John Stocker 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Grant of 1000 shares in lieu of non executive remuneration of #5000 7 Number of shares/amount of stock acquired: 1000 8 Percentage of issued class: 0.04% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 500p 13 Date of transaction: November 27 1998 14 Date company informed: November 27 1998 15 Total holding following this notification: 1000 16 Total percentage holding of issued class following this notification: 0.04% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary END RDAFCOCPKDDBQDB
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions